These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Taiwan experience with etanercept in juvenile rheumatoid arthritis. Lai JH J Microbiol Immunol Infect; 2005 Dec; 38(6):451-4. PubMed ID: 16341348 [No Abstract] [Full Text] [Related]
9. Optic neuritis associated with etanercept therapy in two patients with extended oligoarticular juvenile idiopathic arthritis. Tauber T; Daniel D; Barash J; Turetz J; Morad Y Rheumatology (Oxford); 2005 Mar; 44(3):405. PubMed ID: 15637094 [No Abstract] [Full Text] [Related]
10. The hemophagocytic syndrome/macrophage activation syndrome: a final common pathway of a cytokine storm. Szyper-Kravitz M Isr Med Assoc J; 2009 Oct; 11(10):633-4. PubMed ID: 20077953 [No Abstract] [Full Text] [Related]
11. Psoriasis after treatment of juvenile idiopathic arthritis with etanercept. Peek R; Scott-Jupp R; Strike H; Clinch J; Ramanan AV Ann Rheum Dis; 2006 Sep; 65(9):1259. PubMed ID: 16905590 [No Abstract] [Full Text] [Related]
13. Hypersensitive joint reaction after etanercept treatment in a patient with juvenile rheumatoid arthritis. Guo MM; Yang KD; Yu HR; Kuo HC J Rheumatol; 2011 Mar; 38(3):577-9. PubMed ID: 21362794 [No Abstract] [Full Text] [Related]
14. Etanercept in the treatment of macrophage activation syndrome. Prahalad S; Bove KE; Dickens D; Lovell DJ; Grom AA J Rheumatol; 2001 Sep; 28(9):2120-4. PubMed ID: 11550985 [TBL] [Abstract][Full Text] [Related]
15. Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis. Hagiwara K; Sato T; Takagi-Kobayashi S; Hasegawa S; Shigihara N; Akiyama O J Rheumatol; 2007 May; 34(5):1151-4. PubMed ID: 17444583 [TBL] [Abstract][Full Text] [Related]
16. A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Smith JA; Thompson DJ; Whitcup SM; Suhler E; Clarke G; Smith S; Robinson M; Kim J; Barron KS Arthritis Rheum; 2005 Feb; 53(1):18-23. PubMed ID: 15696578 [TBL] [Abstract][Full Text] [Related]
17. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis. Favalli EG; Arreghini M; Arnoldi C; Panni B; Marchesoni A; Tosi S; Pontikaki I Arthritis Rheum; 2004 Apr; 51(2):301-2. PubMed ID: 15077278 [No Abstract] [Full Text] [Related]
18. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Ravelli A; Caria MC; Buratti S; Malattia C; Temporini F; Martini A J Rheumatol; 2001 Apr; 28(4):865-7. PubMed ID: 11327264 [TBL] [Abstract][Full Text] [Related]
19. Etanercept-induced encephalopathy in a 7-year-old child. Ekici B; Aydın K; Cantez S; Ergül Y; Tatlı B Pediatr Neurol; 2011 Oct; 45(4):271-3. PubMed ID: 21907894 [TBL] [Abstract][Full Text] [Related]
20. Macrophage activation syndrome induced by etanercept in a patient with systemic sclerosis. Sterba G; Sterba Y; Stempel C; Blank J; Azor E; Gomez L Isr Med Assoc J; 2010 Jul; 12(7):443-5. PubMed ID: 20862830 [No Abstract] [Full Text] [Related] [Next] [New Search]